Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: A longitudinal EUSTAR study

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Jaeger, Veronika K ^a   Wirz, Elina G ^a   Allanore, Yannick ^b   Rossbach, Philipp ^a   Riemekasten, Gabriela ^c   Hachulla, Eric ^d   Distler, Oliver ^e   Airò, Paolo ^f   Carreira, Patricia E ^g   Gurman, Alexandra Balbir ^h   Tikly, Mohammed ⁱ   Vettori, Serena ^j   Damjanov, Nemanja ^k   Müller Ladner, Ulf ^l   Distler, Jörg H W ^m   Li, Mangtao ⁿ   Walker, Ulrich A ^a   Ananieva, Lidia ^o   Heitmann, Stefan ^o   Rednic, Simona ^o   Riccieri, Valeria ^o   Szmyrka Kaczmarek, Magdalena ^o   Farge, Dominique ^o   Lapadula, Giovanni ^o   Matucci Cerinic, Marco ^o   Guiducci, Serena ^o   Hunzelmann, Nicolas ^o   Ricci, Massimo ^o   Mihai, Carina ^o   Veale, Douglas ^o   Hesselstrand, Roger ^o   Mariok, Eduardo ^o   Smith, Vanessa ^o   Tarner, Ingo H ^o   Kucharz, Eugene J ^o   Czirják, László ^o   Martinovic, Duska ^o   Solanki, Kamal ^o   Ancuta, Codrina Mihaela ^o   Sibilia, Jean ^o   Paola, Caramaschi ^o   Hassanien, Manal ^o   Kahl, Sarah ^o   Wigley, Frederick ^o   Vanthuyne, Marie ^o   Opris, Daniela ^o   Radominski, Sebastião C ^o   Monaco, Andrea Lo ^o   Corrado, Ada ^o   Koehm, Michaela ^o   Codullo, Veronica ^o   Radim, Bevcar ^o   Loyo, Esthela ^o   Üprus, Maria ^o   Pellerito, Raffaele ^o   Zenone, Thierry ^o   Gabrielli, Armando ^o   Kowal Bielecka, Otylia ^o   Rozman, Blaz ^o   Scorza, Raffaella ^o   Saketkoo, Lesley Ann ^o   Midtvedt, Oyvind ^o   Von Mühlen, Carlos Alberto ^o   Henes, Jörg ^o   Branimir, Ani ^o   Hasler, Paul ^o   Yavuz, Sule ^o   Adler, Sabine ^o   Krummel Lorenz, Brigitte ^o   Posa, Magdalena ^o   Engelhart, Merete ^o   Denton, Christopher ^o   Krasowska, Dorota ^o   Lefebvre, Paloma Garcia De La Peña ^o   Cozzi, Franco ^o   Mouthon, Luc ^o   Rosato, Edoardo ^o   Selmi, Carlo ^o   Sancho, Juan José Alegre ^o   Mallia, Carmel ^o   Limonta, Massimiliano ^o   Seidel, Matthias ^o   Foti, Rosario ^o   Stamp, Lisa ^o   Ullman, Susanne ^o   Stebbings, Simon ^o   Santamaria, Vera Ortiz ^o   Del Galdo, Francesco ^o   De Langhe, Ellen ^o   Mathieu, Alessandro ^o   Sunderkötter, Cord ^o   Eyerich, Kilian ^o   Stamenkovic, Bojana ^o   Novak, Srdan ^o   Sampaio Barros, Percival D ^o   Kayser, Cristiane ^o   Litinsky, Ira ^o   Couto, Maura ^o   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Institut Cochin   (France)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIV LILLE   (France)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f SPEDALI CIVILI   (Italy)

^g HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^h TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^j SECOND UNIVERSITY OF NAPLES   (Italy)

^k UNIVERSITY OF BELGRADE   (Serbia)

^l JUSTUS LIEBIG UNIVERSITY   (Germany)

^m UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

ⁿ PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^o NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ERECTILE DYSFUNCTION; FEMALE; FINGER ULCER; FORCED VITAL CAPACITY; GASTROINTESTINAL SYMPTOM; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INCIDENCE; KIDNEY DISEASE; LONGITUDINAL STUDY; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; RISK FACTOR; SCLERODERMA; SYSTEMIC SCLEROSIS; UROGENITAL TRACT DISEASE; AGED; CLINICAL TRIAL; COMPLICATION; GASTROINTESTINAL DISEASES; HEART DISEASES; KAPLAN MEIER METHOD; KIDNEY DISEASES; LUNG DISEASES; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SKIN DISEASES;

AUTOANTIBODY;

ADULT; AGED; AUTOANTIBODIES; FEMALE; GASTROINTESTINAL DISEASES; HEART DISEASES; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LONGITUDINAL STUDIES; LUNG DISEASES; MALE; MIDDLE AGED; RAYNAUD DISEASE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; SKIN DISEASES;

EID: 84992018224     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163894     Document Type: Article

References (31)

1. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003 May; 29(2):239-54. Doi: 10.1016/S0889-857X(03)00022-X PMID: 12841293
2. Gabrielli A, Avvedimento E V, Krieg T. Scleroderma. N Engl J Med. 2009 May 7; 360(19):1989-2003. Doi: 10.1056/NEJMra0806188 PMID: 19420368
3. Rodnan GP, Lipinski E, Luksick J. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum. 1979 Feb; 22(2):130-40. Doi: 10.1002/art.1780220205 PMID: 420706
4. Hasegawa M, Imura-Kumada S, Matsushita T, Hamaguchi Y, Fujimoto M, Takehara K. Anti-topoisomerase I antibody levels as serum markers of skin sclerosis in systemic sclerosis. J Dermatol. 2013 Feb; 40(2):89-93. Doi: 10.1111/1346-8138.12030 PMID: 23216308
5. Alba MA, Velasco C, Simeoân CP, Fonollosa V, Trapiella L, Egurbide MV, et al. Early- versus late-onset systemic sclerosis: differences in clinical presentation and outcome in 1037 patients. Medicine (Baltimore). 2014 Mar; 93(2):73-81. Doi: 10.1097/MD.0000000000000018 PMID: 24646463
6. Manno RL, Wigley FM, Gelber AC, Hummers LK. Late-age onset systemic sclerosis. J Rheumatol. 2011 Jul; 38(7):1317-25. Doi: 10.3899/jrheum.100956 PMID: 21685299
7. Huègle T, Schuetz P, Daikeler T, Tyndall A, Matucci-Cerinic M, Walker UA, et al. Late-onset systemic sclerosis-a systematic survey of the EULAR scleroderma trials and research group database. Rheumatology (Oxford). 2011 Jan; 50(1):161-5. Doi: 10.1093/rheumatology/keq321 PMID: 20884657
8. Walker UA, Tyndall A, Czirjaâk L, Denton C, Farge-Bancel D, Kowal-Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007 Jul; 66(6):754-63. Doi: https://dx.Doi.org/10.1136/ard.2006.062901 PMID: 17234652
9. Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis. 2010 Jan; 69(1):218-21. Doi: 10.1136/ard.2008.103382 PMID: 19279015
10. Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airò P, et al. A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016 Oct 23; 75(1):163-9. Doi: 10.1136/annrheumdis-2014-206386 PMID: 25342760
11. Assassi S, Sharif R, Lasky RE, McNearney TA, Estrada-Y-Martin RM, Draeger H, et al. Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther. 2010 Jan; 12(5):R166. Doi: 10.1186/ar3125 PMID: 20813056
12. Avouac J, Walker UA, Hachulla E, Riemekasten G, Cuomo G, Carreira PE, et al. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis. 2016 Aug 27; 75(1):103-9. Doi: 10.1136/annrheumdis-2014-205295 PMID: 25165035
13. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology (Oxford). 2006 Oct; 45 Suppl 4:iv14-7. Doi: 10.1093/rheumatology/kel312 PMID: 16980717
14. Omair MA, Lee P. Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis. J Rheumatol. 2012 May; 39(5):992-6. Doi: 10.3899/jrheum.110826 PMID: 22467930
15. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007 Jul; 66(7):940-4. Doi: 10.1136/ard.2006.066068 PMID: 17329309
16. Meier FMP, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis. 2012 Aug; 71(8):1355-60. Doi: 10.1136/annrheumdis-2011-200742 PMID: 22615460
17. Masi AT, Rodnan GP, Medsger TA Jr., Altman RD, D'Angelo WA, Fries JF, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980; 23(5):581-90. Doi: 10.1002/art.1780230510 PMID: 7378088
18. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997 Jun; 49 (6):822-30. Doi: 10.1016/s0090-4295(97)00238-0 PMID: 9187685
19. Valentini G. Undifferentiated Connective Tissue Disease at risk for systemic sclerosis (SSc) (so far referred to as very early/early SSc or pre-SSc). Autoimmun Rev. 2015 Mar; 14(3):210-3. Doi: 10.1016/j.autrev.2014.11.002 PMID: 25461837
20. Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirjaâk L, et al. Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis. 2014 Aug 12; 73 (12):2087-93. Doi: 10.1136/annrheumdis-2013-203716 PMID: 23940211
21. Komoâcsi A, Vorobcsuk A, Faludi R, Pinteâ r T, Lenkey Z, Koè lto G, et al. The impact of cardiopulmonary manifestations on the mortality of SSC: A systematic review and meta-analysis of observational studies. Rheumatology (Oxford). 2012 Jun 1; 51(January):1027-36. Doi: 10.1093/rheumatology/ker357 PMID: 22223705
22. Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol (Hoboken, NJ). 2014 Jun; 66(6):1625-35. Doi: 10.1002/art.38390 PMID: 24591477
23. Nikpour M, Hissaria P, Byron J, Sahhar J, Micallef M, Paspaliaris W, et al. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Res Ther. 2011 Jan; 13(6):R211. Doi: 10.1186/ar3544 PMID: 22189167
24. Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J Clin Invest. 1993 Apr; 91(4):1399-404. Doi: 10.1172/JCI116343 PMID: 8473491
25. Hachulla E, Launay D, Mouthon L, Sitbon O, Berezne A, Guillevin L, et al. Is pulmonary arterial hypertension really a late complication of systemic sclerosis? Chest. 2009 Nov; 136(5):1211-9. Doi: 10.1378/chest.08-3042 PMID: 19429720
26. Nguyen B, Mayes MD, Arnett FC, del Junco D, Reveille JD, Gonzalez EB, et al. HLA-DRB1. 0407 and. 1304 are risk factors for scleroderma renal crisis. Arthritis Rheum. 2011 Feb; 63(2):530-4. Doi: 10.1002/art.30111 PMID: 21280007
27. Matucci-Cerinic M, Bellando-Randone S, Lepri G, Bruni C, Guiducci S. Very early versus early disease: the evolving definition of the many faces of systemic sclerosis. Ann Rheum Dis. 2013 Mar; 72 (3):319-21. Doi: 10.1136/annrheumdis-2012-202295 PMID: 23178210
28. Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000 Nov 1; 43(11):2437-44. Doi: 10.1002/1529-0131(200011)43:11<2437::AIDANR10> 3.0.CO;2-U PMID: 11083266
29. Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, et al. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody. Arthritis Rheum. 2007 Aug; 56(8):2740-6. Doi: 10.1002/art.22747 PMID: 17665460
30. Graf SW, Hakendorf P, Lester S, Patterson K, Walker JG, Smith MD, et al. South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome. Int J Rheum Dis. 2012 Feb; 15(1):102-9. Doi: 10.1111/j.1756-185X.2011.01688.x PMID: 22324953
31. Faludi R, Koè lto G, Bartos B, Csima G, Czirjaâk L, Komoâcsi A. Five-year follow-up of left ventricular diastolic function in systemic sclerosis patients: determinants of mortality and disease progression. Semin Arthritis Rheum. 2014 Oct; 44(2):220-7. Doi: 10.1016/j.semarthrit.2014.04.001 PMID: 24830793